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Abstract
Colon carcinoma rarely metastasizes to the breast and 
it is usually associated with a poor prognosis. Even rarer 
is metastatic seeding of colon cancer cells in an intra-
mammary location after surgery. Including a primary 
breast malignancy in the differential diagnosis of such 
cases is mandatory. We report a rare case of double 
seeding implantation of colon adenocarcinoma inside 
the breast parenchyma and intercostal muscles 6 years 
after resection of a pulmonary metastasis from colon 
adenocarcinoma. The metastasis was revealed by the 
presence of bone metaplasia in the intercostal muscles. 
We discuss how negative immunostaining for estrogen 
receptors, progesterone receptors, and HER-2, along 
with the immunohistochemical pattern of cytokeratin 
(CK) 20+/7−/5− and CDX2-positive immunostaining, 
excludes a primary breast malignancy, namely, a “matrix-
producing” carcinoma, from the differential diagnosis. 
We also present the hypothesis of a paracrine pathoge-
netic mechanism to explain the bone metaplasia.
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Introduction
Breast metastases from colon adenocarcinoma are very 
rare1–4 and may be confused with a primary neoplasm 
of the breast. Because the treatment and outcome of 
primary and secondary malignancies of the breast are 
completely different, an accurate diagnosis is important. 
The expression of estrogen receptors (ERs) and pro-
gesterone receptors (PRs) often suggests the primary 
breast origin of a malignancy, but certain breast carci-
nomas are negative for these receptors. Immunohisto-
chemical assay using the anti-cytokeratin-7 (CK7) and 
anti-cytokeratin-20 (CK20) antibodies has been intro-
duced to assist in differentiating primary and metastatic 
neoplasias. Typical CK7/CK20 patterns are present in 
adenocarcinomas of different origin. In fact, most breast 
carcinomas show a CK7+/CK20− pattern, whereas most 
colon adenocarcinomas are CK7−/CK20+.5 Expression 
of CK5 has been reported in basal-like breast carcino-
mas, which are negative for ER, PR, and HER-2 expres-
sion and enclose an even rarer histotype, known as a 
“matrix-producing” carcinoma, showing cartilaginous 
and/or bone metaplasia.6–8 We report a case of breast 
metastatic seeding of colon cancer cells, developing into 
bone metaplasia, in a woman who had undergone resec-
tion of lung metastasis from colon adenocarcinoma 6 
years earlier. The surgical indications for pulmonary 
metastasis resection were the resectability of the lung 
lesion, and the absence of any sign of local recurrence 
of the primary lesion or of extrapulmonary lesions.9
The rarity of intramammary metastatic seeding, the 
long interval since the lung metastasis resection, and the 
unusual histological picture, with bone metaplasia in 
one of the metastatic sites, made it diffi cult to differenti-
ate the colon cancer metastasis from a primary “matrix-
producing” breast carcinoma. Thus, we stress the 
importance of immunohistochemistry through the pre-
sentation of this case.
Case Report
A 76-year-old woman was referred to us for investiga-
tion of a mammary nodule, which had been misdiag-
nosed as breast ductal infi ltrating carcinoma G2, based 
on needle core biopsy fi ndings at another hospital. Clin-
ically, the nodule was 1.6 cm in maximum diameter 
and located within the breast parenchyma, peripherally, 
between the upper and the lower external quadrant. 
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Hereafter we refer to this nodule as “nodule A.” A 
breast X-ray showed radio-opacity of the unclear 
margins of the nodule in the external upper segment of 
the right breast, not far from the chest wall (Fig. 1).
The patient reported that about 7 years previously, 
she had undergone a left hemicolectomy for adenocar-
cinoma of the descending colon, pT3 N1 M0 (TNM 
Stage IIIB), at another hospital, and that histopatho-
logical examination had revealed vascular invasion. 
Fourteen months later, a single lung metastasis from the 
adenocarcinoma of the colon was detected in the upper 
lobe of the right lung. Computed tomography (CT) scan 
and histological examination revealed that this mass 
was deeply located far from the pleural surface of the 
lung. Thus, the patient underwent a wedge resection of 
the upper lobe of the right lung, with placement of a 
drainage tube, which exited across the fourth intercostal 
space, consistent with the location of the skin scar. From 
the time of the second operation until the discovery of 
the breast nodule, no further treatment was given and 
the patient was not followed up.
On admission, the values of the tumor markers car-
cinoembryonic antigen, tissue polypeptide antigen, and 
carbohydrate antigens 15-3, 125, and 19-9 were within 
the normal range. Chest radiography, abdominal ultra-
sonography, and whole-body bone scintigraphy showed 
no lesions indicative of metastasis. Considering the age 
of the patient, we decided to perform an upper-external 
quadrantectomy of the right breast. After removing this 
quadrant, we palpated another nodular swelling about 
3 cm in diameter in the chest wall below the pectoral 
muscles. Hereafter we refer to this nodule as “nodule 
B.” Raising this nodule with a divaricator revealed a 
tumor within the fourth intercostal space, in the inter-
costal muscle, from which it was then isolated and 
removed. The patient was sent home on day 2 after an 
uneventful recovery.
Histological examination was performed on formalin-
fi xed, paraffi n-embedded hematoxylin–eosin-stained 
sections. Both nodules consisted of neoplastic, moder-
ately differentiated gland tissue, apparently compatible 
with the diagnosis of ductal infi ltrating carcinoma G2. 
No excess mucous production was observed. Interest-
ingly, nodule B contained large areas of bone metapla-
sia, consisting of fully matured bone metaplastic tissue, 
with rows of osteoblasts along the edge of the osseous 
trabeculae (Fig. 2a,b). No bone metaplasia was seen in 
nodule A. Immunostaining was negative for ERs, PRs, 
and HER-2 in both nodules. Reports of colon adenocar-
cinoma metastatic to the lungs justifi ed further immu-
nohistochemical analysis with CK7, CK20, CK5, and 
CDX2. In both nodules, a CK20+/CK7−/CK5−/CDX2+ 
immunohistochemical pattern could be seen (Fig. 2c–e). 
Moreover, in nodule B several slender and atrophic 
muscle fi bers, located very close to the metaplastic 
bone trabeculae and to the neoplastic glands, were 
highlighted by using anti-desmin antibody (Fig. 2f). 
Based on these fi ndings, we excluded primary breast 
malignancy and diagnosed intestinal carcinoma 
metastasis.
The hypothesis of metastatic seeding of malignant 
cancer cells was proposed, even though 5 years had 
elapsed since the pulmonary wedge resection, because 
the site of the two nodules coincided with the path and 
the skin scar of the drainage tube. Histological sections 
of the previously resected primary colon tumor and lung 
metastases were revised, but no bone metaplasia was 
observed. The patient is still alive without further evi-
dence of metastases after a 1.5 year follow-up.
Discussion
The seeding of malignant cancer cells along the path of 
the drainage tube is a rare complication of some surgical 
procedures and of percutaneous drainage. It is most 
frequently reported after percutaneous biliary drainage 
for pancreatic carcinoma10,11 and cholangiocarci-
noma,12–17 after laparotomy resection of colorectal 
cancer18 and, occasionally, for carcinoma of the uterine 
cervix.19,20 The chest wall implantation of cancer cells 
at the drainage tube site has been reported after 
lobectomy,21 pericardiocentesis,22 and needle aspiration 
biopsy23 in patients with pulmonary malignancies. 
According to a recent report, catheter-tract metastasis 
was found in 6.7% of 45 patients treated with indwelling 
pleural catheters for malignant pleural effusions.24 The 
skin is the most common site of the implantation. To 
our knowledge, intramammary dissemination has only 
ever been reported in one patient after percutaneous 
Fig. 1. Mammographic image of the tumor
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Fig. 2. a, b The intramammary nodule (a) and intercostal 
muscle nodule (b) both contained neoplastic, moderately 
differentiated gland tissue. There was no excess mucous 
production. Bone metaplasia was present only in b (a, b 
hematoxylin–eosin, ×200). c Positivity for cytokeratin-20 
immunostaining (×400). d Negativity for cytokeratin-7 immu-
nostaining (×400). e Positivity for CDX2 immunostaining 
(×200). f Microscopic fi ndings of the intercostal muscle nodule. 
Slender and atrophic muscle fi bers, close to the metaplastic 
bone trabeculae and to the neoplastic glands, were highlighted 
by the anti-desmin antibody (anti-desmin immunostaining, 
×200)
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transthoracic needle aspiration biopsy of a pulmonary 
neoplasm.23
There are several interesting clinical and histological 
aspects of this case: the intramammary localization 
of one of the two nodules; the long interval after the 
lung lobectomy; and the presence of bone metaplasia, 
observed only in the intercostal muscle nodule but 
absent in the intramammary nodule and in the previ-
ously resected specimens of colon carcinoma and lung 
metastasis. Cartilaginous and/or bone metaplasia have 
been reported in the rare “matrix-producing” carci-
noma, which shows negative immunostaining for ERs, 
PRs, and HER-2 and positive immunostaining for 
CK5 expression, and is included within the basal-like 
phenotype.6–8 Although CK7 expression is present in 
most breast carcinomas, it is noteworthy that it was 
reported in one case of “matrix-producing” carcinoma25 
and in some metaplastic spindle cell carcinomas.26 On 
the contrary, no primary breast carcinomas have been 
reported to be positive for CK20 immunostaining. 
Finally, the positive immunostaining for CDX2, a highly 
sensitive and specifi c marker of colon carcinoma,27 
along with the CK20+/CK7−/CK5− immunohistochemi-
cal pattern, made the diagnosis of a primary breast 
carcinoma unlikely and led us to hypothesize that the 
patient had double synchronous breast and chest wall 
metastases of colon adenocarcinoma, one of which had 
bone metaplasia.
Bone metaplasia is a rare phenomenon more often 
described in metastasis of colon carcinomas and biliary 
tract carcinomas. The pathogenesis is still not fully 
understood, but it is speculated that the extravasation 
of mucin may play a stimulatory role.28,29 It was sug-
gested recently that bone metaplasia may result from 
the metaplasia of pluripotent stem cells into osteoblast 
cells induced by bone morphogenetic proteins (BMP-2, 
-4, -6, -7),30 among which BMP-2 may play an important 
paracrine role.31 In the model designed by Lee et al.32 to 
study the early stage of osteoblast differentiation during 
bone formation in muscle tissues, treatment with BMP-2 
not only blocked the myogenic differentiation of C2C12 
pluripotent mesenchymal precursor cells but also 
induced osteoblast differentiation.
Heterotopic ossifi cation in skeletal muscle metastasis 
from colonic adenocarcinoma has also been reported.33,34 
However, we observed no excess mucus production in 
our patient, so a stimulatory role of mucins could not 
be hypothesized. Furthermore, the presence of mature 
bone metaplasia next to the muscle fi bers and neoplastic 
glands suggests a close relationship between these three 
elements, consistent with the hypothesis of a paracrine 
mechanism of osteogenesis induction in muscle pluripo-
tent mesenchymal cells by cytokines produced by the 
neoplastic cells. Further experimental studies to verify 
this hypothesis are warranted.
Metastatic breast tumors from colon adenocarcinoma 
are rare and are usually indicative of disseminated 
disease, with a poor prognosis.2–4 However, our patient 
has no sign of further metastases even after 1.5 years of 
follow up. This suggests that a metastatic tumor to the 
breast from colon adenocarcinoma is unlikely, and 
supports the possibility of a double malignant seeding 
implantation after the lung metastasis resection. To our 
knowledge, this is the fi rst report of a synchronous 
double seeding implantation metastasis along the drain-
age tube path in the breast parenchyma and in the inter-
costal muscle, with bone metaplasia. We emphasize the 
rarity of this case and the peculiarity of the clinical 
course and histological fi ndings, highlighting the role of 
CK7, CK20, CK5, and CDX2 immunoassay in the dif-
ferential diagnosis with a primary breast malignancy.
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